NovaLisa® Leishmania infantum IgG

NovaLisa® Leishmania infantum IgG (96 tests) - LEIG0310

Enzyme-linked immunosorbent assay intended for the qualitative detection of IgG antibodies against Leishmania infantum in human serum or plasma (citrate, heparin).

  • Ready-to-use, color-coded reagents, and breakable strip plates
  • Standardized methods suitable for automated procedures
  • CE-IVD

Disease: Leishmania infantum: Visceral leishmaniasis (VL) Leishmania major: Cutaneous leishmaniasis (CL) Leishmania brasiliensis: mucocutaneous leishmaniasis (MCL) Leishmania mexicana: diffuse cutaneous leishmaniasis (DCL)

Symptoms: Irregular bouts of fever, substantial weight loss, swelling of spleen and liver and anaemia. Self-limiting skin lesions. Skin ulcers, which can spread and cause hideous tissue destructions. Disseminated and chronic lesions which resemble those of lepromatous leprosy.

Mechanism of Infection: Transmission (along with the saliva) by the bite of infected female sandflies of the genus Phlebotomus in the Old World and Lutzomya in the New World.

LEIG0310
Product
Order no.
Format
Wishlist
NovaLisa® Leishmania infantum IgG
Order no. LEIG0310
Format96 tests
Add to wishlist

Documents

Name
Document type
Language
Format
Document
NovaLisa® Leishmania infantum IgG (96 tests) - LEIG0310 Rev. 01
IFUIFU
Language
Formatpdf
This document is only available for registered users. Login to reach it.
NovaLisa® Leishmania infantum IgG
CoACoA
Language
Formatpdf
This document is only available for registered users. Login to reach it.
NovaLisa® Leishmania infantum IgG
MSDSMSDS
Formatpdf
This document is only available for registered users. Login to reach it.